Nutrigenomics Market Size Global Gathering and Future Outlook 2020 to 2026

Posted by peeterdbmr on May 27th, 2021

Global nutrigenomics market is expected to rise to an estimated value of USD 28.27 billion by 2026, registering a healthy CAGR in the forecast period of 2020-2026. Nutrigenomics is a field of life-science which involves testing the DNA and gene samples of individuals so that they can be provided with specially required nutrients, diet and healthcare services. This involves organizing the data based on different needs of genes tested on, and providing patients with specialized nutritional needs according to their metabolism.

Segmentation: Global Nutrigenomics Market

•          By Product (Reagents & Kits, Services)
•          By Technique (Saliva, Buccal Swab, Blood, Others)
•          By Application (Obesity, CVD, Diabetes, Anti-Aging, Cancer Research)
•          By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) 

Download PDF Sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nutrigenomics-market

Key Market Competitors: Global Nutrigenomics Market

Few of the major competitors currently working in the global nutrigenomics market are Koninklijke DSM N.V.; BASF SE; Unilever; Genova Diagnostics; Nutrigenomix; Metagenics, Inc.; Cell-Logic; GX Sciences, Inc.; CURA INTEGRATIVE MEDICINE; Xcode Life; The Gene Box; Orig3n; Geneus Health, LLC; NutriProCan; Seven Oaks General Hospital,part of Winnipeg Regional Health Authority and Prenetics Limited, among others.

Competitive Analysis: Global Nutrigenomics Market

Global nutrigenomics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of nutrigenomics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

•          Focus on advancements in the market resulting in technological advancements of proteomics, metabolomics, computation biology, genomics and bioinformatics; this factor is expected to drive the growth of the market
•          Growing levels of research & developments to prevent cases of cancer globally acts as a market driver
•          Growing concerns regarding the health of individuals resulting in need for personalized nutrition intake will also boost the market growth
•          Growth in the application areas of the technology uplifts the growth of this market

Market Restraints

•          Requirement of large capital and resources for the implementation of this method; this factor is expected to restrain the market growth
•          Requirement of skilled professionals and physicians to utilize this technology and their results will hamper the market growth
•          Concerns regarding ethical nature of this technology also acts as a restricting factor in the growth of this market in the forecast period